Bottom line
Is HAPS a good fund? The bottom line
HAPS is an actively managed small-cap ETF from Oakmark (Harris).
Annual fees run 0.61% — about $61 a year on every $10,000 invested, cheaper than 86% of small-cap funds we track.
It returned +8.4% over one year (as of Dec 31, 2025, per its prospectus).
With $171 million in net assets and 195 holdings, its largest position is Twist Bioscience Corp (2.9%) and the top 10 make up 18% of the portfolio.
What stands out
- Low cost: cheaper than 86% of small-cap peers
Updated Nov 19, 2026
What HAPS invests in
The Fund seeks to provide investment results that correspond, before fees and expenses, to the performance of the Human Capital Factor Small Cap Index (the Index).
The Fund employs an indexing investment approach designed to track the performance of the Index. The Fund invests at least 80% of its total assets in securities that are included in the Index. The Index consists of a modified market capitalization-weighted portfolio of equity securities of approximately 200 small cap U.S. companies identified by Irrational Capital LLC (Irrational Capital or IC) as those it believes to possess strong corporate culture based on its proprietary scoring methodology. The Index was developed by the Canadian Imperial Bank of Commerce (the Index Provider or CIBC). Irrational Capital calculates Human Capital Factor scores based on a proprietary, rules-based scoring methodology it developed by leveraging its research in behavioral science, data science and human capital. The scoring methodology seeks to quantitatively measure the contribution of a companys…
From the fund's prospectus (filed Feb 27, 2026).
HAPS performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| HAPS | +8.4% | — | — |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What HAPS costs
On a $10,000 investment, HAPS's 0.61% expense ratio costs about $61 a year. The prospectus estimates $762 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
HAPS top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Twist Bioscience Corp | 2.86% |
| 2 | Kymera Therapeutics Inc | 2.21% |
| 3 | Phillips Edison & Co Inc | 1.97% |
| 4 | Organon & Co | 1.71% |
| 5 | Magnolia Oil & Gas Corp | 1.64% |
| 6 | Sensient Technologies Corp | 1.62% |
| 7 | Resideo Technologies Inc | 1.59% |
| 8 | Avnet Inc | 1.59% |
| 9 | Apple Hospitality REIT Inc | 1.49% |
| 10 | Viasat Inc | 1.37% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 18% of the fund. See all top 25 holdings and asset mix →